Contribution of BCR-ABL kinase domain mutations to imatinib mesylate resistance in Philadelphia chromosome positive Malaysian chronic myeloid leukemia patients

Development of resistance to imatinib mesylate (IM) in chronic myeloid leukemia (CML) patients is mediated by different mechanisms that can be classified as <em>BCR-ABL</em> dependent or <em>BCR-ABL</em> independent pathways. <em>BCR-ABL</em> dependent mechanisms are most frequently associated with...

Fuld beskrivelse

Bibliografiske detaljer

Principais autores:	Marjanu Hikmah Elias, Abdul Aziz Baba, Azlan Husin, Abu Dzarr Abdullah, Rosline Hassan, Goh Ai Sim, S. Fadilah Abdul Wahid, Ravindran Ankathil
Format:	Artigo
Sprog:	Inglês
Udgivet:	MDPI AG 2012-11-01
Serier:	Hematology Reports
Fag:	chronic myeloid leukemia, imatinib mesylate, BCR-ABL dependent mechanisms, tyrosine kinase domain, mutation
Online adgang:	http://www.pagepress.org/journals/index.php/hr/article/view/4413
Tags:	Tilføj Tag Ingen Tags, Vær først til at tagge denne postø!